Studies reveal resistance to tecovirimat in mpox patients with weak immune systems (By: Mary Van Beusekom, MS)
Ninety-six isolates from 46 US mpox patients were resistant to the antiviral drug tecovirimat (Tpoxx), although most were from patients with severely weakened immune systems who took multiple courses of the drug, according to a study published…









